CStone Pharmaceuticals (CSPHF)
USD 0.52
(61.37%)
USD 0.52
(61.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 363.44 Million CNY | 26.95% |
| 2022 | 286.29 Million CNY | 64.35% |
| 2021 | 174.19 Million CNY | 107.73% |
| 2020 | 83.85 Million CNY | 1830.46% |
| 2019 | 4.34 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 306.42 Million CNY | 9.22% |
| 2024 Q1 | 306.42 Million CNY | -3.94% |
| 2023 Q3 | 330.12 Million CNY | 75.89% |
| 2023 FY | 363.44 Million CNY | 26.95% |
| 2023 Q1 | 187.68 Million CNY | -34.44% |
| 2023 Q4 | 318.98 Million CNY | -3.37% |
| 2023 Q2 | 187.68 Million CNY | 0.0% |
| 2022 Q1 | 192.02 Million CNY | 10.24% |
| 2022 Q4 | 286.29 Million CNY | 14.54% |
| 2022 Q2 | 236.79 Million CNY | 23.31% |
| 2022 FY | 286.29 Million CNY | 64.35% |
| 2022 Q3 | 249.93 Million CNY | 5.55% |
| 2021 Q1 | 87.85 Million CNY | 4.76% |
| 2021 FY | 174.19 Million CNY | 107.73% |
| 2021 Q4 | 174.19 Million CNY | 8.23% |
| 2021 Q3 | 160.95 Million CNY | 64.91% |
| 2021 Q2 | 97.59 Million CNY | 11.1% |
| 2020 Q2 | 25.49 Million CNY | 6.7% |
| 2020 Q1 | 23.89 Million CNY | 450.07% |
| 2020 FY | 83.85 Million CNY | 1830.46% |
| 2020 Q4 | 83.85 Million CNY | 11.5% |
| 2020 Q3 | 75.2 Million CNY | 194.99% |
| 2019 Q3 | - CNY | -100.0% |
| 2019 FY | 4.34 Million CNY | 0.0% |
| 2019 Q2 | 7.18 Million CNY | 409.72% |
| 2019 Q1 | 1.4 Million CNY | 0.0% |
| 2019 Q4 | 4.34 Million CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 20.32 Million USD | -1687.918% |
| Skye Bioscience, Inc. | 4.61 Million USD | -7774.909% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -1120.971% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -296592.245% |
| Qrons Inc. | 351.84 Thousand USD | -103197.172% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -6090.469% |
| BioStem Technologies, Inc. | 4.71 Million USD | -7614.197% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -47962.163% |
| CSL Limited | 12.18 Billion USD | 97.017% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -697.735% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -737.959% |
| Rebus Holdings, Inc. | 310 Thousand USD | -117141.29% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -57583.109% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -1413049.811% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -782.091% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -8717.365% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -90343.923% |
| SQZ Biotechnologies Company | 27.47 Million USD | -1223.024% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -15525.754% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -38227.44% |
| Mesoblast Limited | 118.7 Million USD | -206.189% |
| Marizyme, Inc. | 18.71 Million USD | -1841.756% |
| Genus plc | 233.1 Million USD | -55.919% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -12302.726% |
| Pharming Group N.V. | 171.54 Million USD | -111.867% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -40825.879% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -26950.635% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -48359.733% |
| ContraFect Corporation | 2.88 Million USD | -12515.342% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -268153.043% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -25029.173% |
| IMV Inc. | 28.88 Million USD | -1158.307% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -6323.212% |
| MultiCell Technologies, Inc. | 202.58 USD | -179409515.954% |
| ONE Bio Corp. | 19.71 Million USD | -1743.508% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -532.204% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -24214.953% |
| Q BioMed Inc. | 4.1 Million USD | -8743.058% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -997.997% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -29488.045% |
| Biomind Labs Inc. | 735.54 Thousand USD | -49312.27% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -437.304% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -11910.081% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -2696.4% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -100939.17% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -256721.04% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -15993.299% |
| GB Sciences, Inc. | 1.75 Million USD | -20558.589% |
| Alpha Cognition Inc. | 1.22 Million USD | -29681.739% |
| HST Global, Inc. | 98.31 Thousand USD | -369562.019% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -146027.372% |
| Halberd Corporation | 150 Thousand USD | -242198.667% |
| Enzolytics Inc. | 996.33 Thousand USD | -36378.384% |
| Agentix Corp. | 50 Thousand USD | -726796.0% |
| Resverlogix Corp. | 6.49 Million USD | -5499.261% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -142098.504% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -1717.24% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -5038.665% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -13317.787% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -3554403.667% |
| Genscript Biotech Corporation | 417.73 Million USD | 12.996% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -181066.009% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -15058.042% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -158409.492% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -244392.58% |
| Kadimastem Ltd | 891.22 Thousand USD | -40680.677% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -145173.441% |
| LadRx Corporation | 33.6 Thousand USD | -1081397.352% |
| Cell Source, Inc. | 9.25 Million USD | -3827.395% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -47962.163% |
| NovAccess Global Inc. | 2.19 Million USD | -16421.265% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -159043.872% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -172170.648% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -7193.759% |
| Mobile Lads Corp. | 484.28 Thousand USD | -74948.525% |
| CytoDyn Inc. | 30.07 Million USD | -1108.432% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -4547.696% |
| SYBLEU INC | 477.5 Thousand USD | -76014.764% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -7575.319% |
| International Stem Cell Corporation | 4.17 Million USD | -8599.09% |
| Bioxytran, Inc. | 1.92 Million USD | -18780.416% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -582227.4% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -16565.047% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -4270.467% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -4133.524% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -23265.664% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -135514.925% |
| Neutra Corp. | 54.15 Thousand USD | -671013.081% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -19760.546% |
| PureTech Health plc | 25.51 Million USD | -1324.616% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -29587.982% |
| IXICO plc | 472.02 Thousand USD | -76897.943% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -2244.675% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -483.73% |
| CSL Limited | 12.18 Billion USD | 97.017% |
| Cellectis S.A. | 92.77 Million USD | -291.746% |